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Abstract
The Na
+/K
+-ATPase plays a pivotal role during preimplantation development; it establishes a trans-epithelial ionic gradient
that facilitates the formation of the fluid-filled blastocyst cavity, crucial for implantation and successful pregnancy. The Na
+/
K
+-ATPase is also implicated in regulating tight junctions and cardiotonic steroid (CTS)-induced signal transduction via SRC.
We investigated the expression of SRC family kinase (SFK) members, Src and Yes, during preimplantation development and
determined whether SFK activity is required for blastocyst formation. Embryos were collected following super-ovulation of
CD1 or MF1 female mice. RT-PCR was used to detect SFK mRNAs encoding Src and Yes throughout preimplantation
development. SRC and YES protein were localized throughout preimplantation development. Treatment of mouse morulae
with the SFK inhibitors PP2 and SU6656 for 18 hours resulted in a reversible blockade of progression to the blastocyst stage.
Blastocysts treated with 10
23 M ouabain for 2 or 10 minutes and immediately immunostained for phosphorylation at SRC
tyr418 displayed reduced phosphorylation while in contrast blastocysts treated with 10
24 M displayed increased tyr418
fluorescence. SFK inhibition increased and SFK activation reduced trophectoderm tight junction permeability in blastocysts.
The results demonstrate that SFKs are expressed during preimplantation development and that SFK activity is required for
blastocyst formation and is an important mediator of trophectoderm tight junction permeability.
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Introduction
Blastocyst formation is a prerequisite for the initiation of
pregnancy, however, the majority of mammalian preimplantation
embryos fail to complete this developmental interval and implant
[1–5]. This restricted developmental success greatly reduces the
efficiency of methods aimed at fostering both animal and human
assisted reproduction. As such, there is a requirement to increase
our understanding of the cellular and molecular mechanisms that
control preimplantation development, and in particular, blastocyst
formation [1–5]. In addition, preimplantation development
encompasses the first cell differentiation events of development
including the formation of the epithelial trophectoderm and the
pluripotent inner cell mass [1–9]. Research directed at under-
standing the mechanisms that control trophectoderm differentia-
tion, and thus blastocyst formation, also serves to provide
fundamental insight into the mechanisms controlling epithelial
cell differentiation throughout development and the mechanisms
controlling acquisition of cell polarity [10–13].
Blastocyst formation is regulated by the combined actions of ion
transporters, water channels, and intercellular junctions [1–3,5].
We have hypothesized that blastocyst formation is regulated by the
action of a polarized basolateral localized Na
+/K
+-ATPase that
creates a trans-trophectodermal ion gradient [3,14–25]. This
facilitates water movement across the epithelium, in conjunction
with aquaporin water channels, to form the blastoceolic fluid
[16,26,27]. The blastocyst expands via the continued movement of
this fluid across the epithelium, but this does not occur until a fully
developed and functional tight junction complex between adjacent
trophectoderm cells is formed [7,14,28–31]. Thus, blastocyst
formation is regulated by the formation of this trophectoderm tight
junctional seal. While research has uncovered the principal
molecular constituents of the mechanism controlling blastocyst
formation we know relatively little about the regulation of each
individual component.
Ouabain is a cardiotonic steroid that is primarily known as a
plant-derived chemical that specifically binds to the Na
+/K
+-
ATPase to modulate the ion transport function of the pump [32–
44]. Recent research has established that ouabain and other
cardiotonic steroids are in fact a newly discovered group of
endogenous steroid hormones that are produced primarily by the
adrenal glands [32–44]. This discovery has directed research
towards understanding the physiological roles of endogenous
cardiotonicsteroids inregulating Na
+/K
+-ATPasefunction [32–44].
In addition to regulating Na
+/K
+-ATPase ion transport,
research applied primarily to cell lines has indicated that ouabain
binding to the cell also regulates SRC pathway signalling [45–50].
These discoveries have indicated that ouabain binding to its Na
+/
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+-ATPase receptor regulates cellular function via activation of
SRC and its downstream mechanisms [45–50]. We have
hypothesized that this ouabain-mediated, SRC-activated pathway
plays an important role in regulating preimplantation develop-
ment by regulating trophectoderm tight junction function.
In this study we present evidence for the expression of Src family
kinase members, Src and Yes, during preimplantation develop-
ment. We establish concentrations of ouabain that both activate
and inhibit SFK activation at the blastocyst stage. Furthermore,
we demonstrate that SFK activity is necessary for blastocyst
formation, and more specifically, regulates trophectoderm tight
junction function. We therefore conclude that the developing
blastocyst has the capacity to respond to ouabain by activating
SFKs and that this process is an important mediator of tight
junction function, and thus overall blastocyst formation.
Results
Detection of Src and Yes mRNAs during Mouse
Preimplantation Development
Src and Yes mRNAs were consistently detected, using RT-PCR
applied to three preimplantation development series (1-cell, 2-cell,
4-cell, 8-cell, morula and blastocysts) experimental replicates,
throughout mouse preimplantation development (Figure 1A). The
PCR products were sequenced and displayed a 100% sequence
identity to mouse Src and Yes sequences in the NCBI database.
Localization of SRC and Yes Protein throughout
Preimplantation Development
SRC protein was detected at the 2-cell stage, by immunoflu-
orescence, as a fluorescent ring encircling the periphery of each
blastomere (Figure 1B). Upon reaching the 8-cell stage, SRC
protein fluorescence diminished but reappeared in each blasto-
mere of 8-cell compacting embryos, especially at areas of cellular
contact in the basolateral domain of the plasma membrane. By the
blastocyst stage, the cortical fluorescent pattern encircling each
blastomere was maintained in both trophectoderm and inner cell
mass (Figure 1B).
YES protein was also detected throughout mouse preimplan-
tation development. At the 2-cell stage, the protein was diffusely
localized in each blastomere, but the cortical distribution observed
for SRC was also evident for YES (Figure 1B). The YES
fluorescent signal also decreased at the 8-cell stage and became
more obvious post compaction. The blastocyst displayed YES
protein fluorescence in both ICM and TE cells, however YES
protein fluorescence was never as intense as that observed for SRC
protein in any preimplantation developmental stage (Figure 1B).
Effects of Ouabain Treatment on SRC Activation
We next investigated the effects of ouabain treatment on SFK
activation during blastocyst formation. We employed standardized
concentrations of ouabain (10
23 M), that are known to block the
ion transport functions of the Na
+/K
+-ATPase in the mouse
[14,19,23,51–53] and concentrations (10
24 M) that do not. After a
2 minute ouabain treatment, blastocysts exhibited consistent
variations in SRC tyr418 phosphorylation (Figure 2A). The
10
23 M ouabain concentration resulted in a marked reduction in
tyr418 phosphorylation fluorescence, while treatment with
10
24 M ouabain for 2 minutes increased tyr418 phosphorylation
fluorescence (Figure 2A). Both tyr418 phosphorylation fluores-
cence levels were compared to baseline levels in control embryos
cultured in KSOMaa medium without drug and to no primary
antibody controls. The total number of embryos used for no
antibody (negative) control, KSOMaa, 10
23 M ouabain, and
10
24 M ouabain treatment groups, respectively, was 23, 21, 18,
26. These results demonstrate that ouabain treatment affects SRC
phosphorylation at the blastocyst stage.
Following a 10 minute ouabain treatment, a greater difference
in SRC tyr418 fluorescence in blastocysts was observed between
treatment groups. Blastocysts cultured in 10
23 M ouabain
displayed a prominent reduction in SRC tyr418 phosphorylation
fluorescence when compared to KSOMaa controls (Figure 2B). In
turn, blastocysts treated with 10
24 M ouabain for 10 mins
exhibited increased SRC tyr418 phosphorylation fluorescence.
The total number of embryos used for no antibody (negative)
control, KSOMaa, 10
23 M ouabain, and 10
24 M ouabain
treatment groups, respectively, were 10, 24, 32, 32. These results
demonstrate the ability of different concentrations of ouabain and
varying treatment times to induce disparate changes in SRC
phosphorylation fluorescence in blastocysts. A high ouabain
concentration, that blocks progression to the blastocyst stage,
elicited reduced phosphorylation fluorescence levels on tyr418,
indicating reduced SRC activity. A lower ouabain concentration
that does not reduce development to the blastocyst stage elevated
tyr418 phosphorylation fluorescence levels, indicating increased
SRC activity.
Effect of PP2 Treatment on Cavitation and SRC
Phosphorylation
Next we investigated the role of SFK signaling in regulating
preimplantation development and more specifically on the
regulation of trophectoderm tight junction permeability. Morulae
treated with PP2 displayed a significant reduction in blastocyst
formation after an 18 hour treatment at 20 mM, 30 mM and
50 mM, when compared to both control groups, P#0.05
(Figure 3A). Of the control embryos, 63% of morulae cultured
in KSOMaa cavitated, while 69% of DMSO+KSOMaa cultured
embryos cavitated. For morulae cultured in 20 mM, 30 mM and
50 mM PP2, 33%, 25% and 18% of the treated embryos cavitated,
respectively (Figure 3A). All embryos blocked from cavitating due
to SFK inhibition were able to recover and progress to the
blastocyst stage at levels comparable to control embryos when
placed back into drug free KSOMaa media, P#0.05 (Figure 3B).
The respective cavitation frequencies for each recovered treatment
group, presented with standard error of means are: 9464%,
9365%, 9768%, 80%68, 70612% with the total number of
embryos examined in each treatment group equaling 59, 78, 79,
70, 70. This result demonstrates that SRC activity facilitates
blastocyst formation.
Embryos were randomly selected and removed from each
treatment group (KSOMaa, DMSO+KSOMaa, 20 uM PP2,
30 uM PP2 and 50 uM PP2) following the initial 18 hour culture
period and were fixed instead of being placed into the recovery
KSOMaa culture experiment. Application of immunofluorescence
methods for phosphorylation on tyr418 of SRC revealed a
concentration dependent loss of tyr418 phosphorylation of SRC
after treatment in PP2, when compared to embryos in the
KSOMaa or DMSO+KSOMaa (Figure 3C–H). This outcome
validated that PP2 treatment effectively blocks SRC phosphory-
lation on tyr418. The total number of embryos utilized for
immunofluorescence for each treatment group was, respectively, 4,
8, 12, 15, 8, 12.
Effect of SU6656 Treatment on Cavitation and SRC
Activation
A second SFK inhibitor, SU6656, was used to test for
consistency of outcomes after SFK inhibition. Morulae cultured
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cavitate after an 18 hour treatment period, P#0.05 (Figure 3I).
Seventy-seven67% of the embryos cultured under drug free
KSOMaa conditions cavitated, while 6368% of those cultured in
DMSO+KSOMaa cavitated. Sixty-five616% of the embryos
cultured in 1 mM SU6656 cavitated while 1865% in 5 mM
treatment and only 1666% of those in the 10 mM treatment
cavitated. The total number of embryos in each group were, 40,
61, 47, 44, 43 respectively (Figure 3I). Once again the effects of
treatment were reversible as blocked embryos placed into fresh
KSOMaa after SU6656 treatment, recovered and cavitated to
levels comparable to embryos cultured under control conditions,
which were for the respective groups: 9367%, 9264%, 8263%,
89611% and 9268% with the total number of embryos
examined for recovery in each treatment group equaling 7, 26,
28, 24, 19. (Figure 3J) Embryos were selected and randomly
allocated from the SU6656 treatment experiment from each
treatment and fixed for use in indirect immunofluoresence.
Embryos were tested for phosphorylation on tyr418 of SRC,
which was blocked in a concentration dependent manner by
SU6656 treatment when compared to either KSOMaa or
DMSO+KSOMaa control groups (Figure 3K–P). The total
Figure 1. A,B. Detection of SFK (Src and Yes) mRNA and protein during Mouse Preimplantation Development. mRNAs encoding Yes
and Src mRNAs were detected during preimplantation development (1C, 1-cell; 2C, 2-cell; 4C, 4-cell; 8C, 8-cell; M, morula; B, blastocyst; L, low mass
ladder with 300 and 400 b.p. visible). Lung tissue RT positive controls (+) and no cDNA template negative controls (2) are shown. Representative of 3
independent experiments. In the 2-cell stage, SRC was localized to the cell cortex. SRC immunofluoresence diminished in the 8-cell embryo, but
reappeared at areas of cellular contact in the compacted 8-cell embryo, as well as in all trophectoderm (TE) and inner cell mass (ICM) cells in
blastocysts. At the 2-cell stage, YES immunofluorescence consisted of diffuse cytoplasmic staining. YES immunofluorescence diminished in the 8-cell
embryo, but reappeared during compaction and was detectable in all cells, TE and ICM, of the blastocyst. Negative controls represent embryos
incubated with FITC-conjugated secondary only (no primary antibody), in addition to DAPI. In all confocal micrographs, green indicated positive
staining for proteins and blue indicates DAPI nuclear staining. Scale bars represent 10 mm.
doi:10.1371/journal.pone.0023704.g001
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control, KSOMaa, DMSO, 1 mM, 5 mM, or 10 mM SU6656
treatment groups was 3, 15, 20, 12, 12, 8. This result validates the
efficacy of SU6656 to block phosphorylation of tyr418 in mouse
preimplantation embryos. These results demonstrated the ability
of a second SFK inhibitor to produce consistent outcomes. In
total the results demonstrate that SFK activation is required for
blastocyst formation to occur.
Permeability of Trophectoderm Tight Junctions to 4 kDa
FITC-Dextran Following Ouabain and PP2 Treatment
4 kDa FITC-dextran was used to test the permeability of
trophectoderm tight junctions in fresh flushed mouse blastocysts
[23]. Of the blastocysts in KSOMaa for 3 hours (controls),
2262% were permeable to 4 kDa FITC-dextran, showing the
baseline permeability level of mouse blastocysts (Figure 4A,E).
Blastocysts treated in 2 mM EGTA, which increased tight junction
permeability, displayed 4865% permeability to 4 kDa FITC-
dextran (Figure 4B,E). Inhibiting SRC through treatment with
20 mM PP2 resulted in 3461% of the blastocysts displaying
permeablity to 4 kDa FITC-dextran, while treating with 10
24 M
ouabain decreased tight junction permeability to 1163%
(Figure 4C–D,E). The total number of embryos placed in each
group were 97, 89, 91, 100 (Figure 4E). All treatment groups were
statistically significant to each other when analyzed using the
Student-Neuman-Keul analysis method, P#0.05. These results
suggest a relationship between SRC activity and tight junction
function in the mouse blastocyst, since SRC inhibition increased
tight junction permeability and SRC activation decreased tight
junction permeability.
Figure 2. A–H. Effect of 2-minute and 10-minute Ouabain Treatment on SFK Phosphorylation and Activation at the Blastocyst
Stage. Negative controls represent blastocysts exposed to FITC-conjugated secondary antibody only (no primary antibody) in addition to DAPI (A,E).
The top row illustrates embryos merged with DAPI and FITC staining, while the bottom row illustrates FITC staining alone. In KSOMaa cultured
controls, phosphorylated tyr418 of SRC was detected in the cytoplasm of blastocysts (B,F). Following a 2 minute treatment, phosphorylation
decreased with (C)1 0
23 M ouabain treated embryos but increased in (D)1 0
24 M ouabain treated embryos. Following a 10 min treatment,
phosphorylation fluorescence remained low (G)i n1 0
23 M ouabain treated embryos but remained high (H)i n1 0
24 M ouabain treated embryos.
Green FITC staining indicates positive staining for phosphorylation of tyr418 on SRC and blue DAPI staining indicates nuclei. Scale bars are 10 mm.
doi:10.1371/journal.pone.0023704.g002
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PLoS ONE | www.plosone.org 4 August 2011 | Volume 6 | Issue 8 | e23704Figure 3. A–P. Effect of PP2 and SU6656 Treatment on Blastocyst Formation. Percentage of embryos developing from compacted morula
to the blastocyst stage after 18 hours of culture in either KSOMaa, KSOMaa+DMSO, or KSOMaa plus 20 mM PP2, 30 mM PP2 or 50 mM PP2 (A–H). All
PP2 concentrations significantly blocked the cavitation of morulae compared to KSOMaa or KSOMaa+DMSO vehicle controls (A). Standard error
means are indicated by error bars. Percentage of embryos developing to the blastocyst stage after 18 hours of culture in either KSOMaa,
KSOMaa+DMSO, and KSOMaa plus 20 mM PP2, 30 mM PP2 or 50 mM PP2 followed by a recovery culture period of 18 hours in KSOMaa (B). Embryos
resumed development and reached the blastocyst stage, regardless of PP2 treatment, to levels comparable to either control group. (B). Whole-mount
immunofluorescence labelling of blastocysts with anti-phospho-tyr418 of SRC (C–H). Negative control embryos that were incubated in FITC-
conjugated secondary only (no primary antibody) (C). Images demonstrate baseline phosphorylation in (D) KSOMaa or (E) KSOMaa+DMSO controls
and reduced phosphorylation after treatment with (F)2 0mM, (G)3 0mM, or (H)5 0mM PP2 for 18 hours. Percentage of morula cavitating after
18 hours of culture in KSOMaa, KSOMaa+DMSO, 1 mM SU6656, 5 mM SU6656 or 10 mM SU6656 (I). Experimental concentrations of 5 mM and 10 mM
SU6656 significantly blocked cavitation when compared to KSOMaa control or KSOMaa+DMSO vehicle controls. Error bars indicate standard error
means. Percentage of embryos developing to the blastocyst stage after 18 hours of culture in KSOMaa, KSOMaa+DMSO, 1 mM SU6656, 5 mM SU6656
or 10 mM SU6656 followed by a recovery culture period of 18 hours in KSOMaa (J). Treated embryos progressed to the blastocyst stage, regardless of
SU6656 concentration, to levels comparable to either control treatment group. Whole-mount immunofluorescence labelling of blastocysts with anti
phospho-tyr418 of SRC (K–P). Negative control embryos were exposed to FITC-conjugated secondary only (no primary antibody) (K). Images
demonstrate baseline phosphorylation levels after treatment with (L) KSOMaa or (M) KSOMaa plus DMSO for 18 hours, and reduced phosphorylation
after treatment with (N)1mM, (O)5mM, or (P)1 0mM SU6656 for 18 hours. Green FITC fluorescence indicates phosphorylation of tyr418 of SRC. Scale
bars represent 10 mm.
doi:10.1371/journal.pone.0023704.g003
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40 kDa FITC-dextran Following Ouabain and PP2
Treatment
A second, larger, molecular weight FITC-dextran was utilized
to further demonstrate the effects on tight junction permeability in
blastocysts after treatments identical to the 4 kDa FITC-dextran
trial. These experiments demonstrated baseline permeability of
blastocysts to 40 kDa FITC-dextran was 2462% (Figure 4F,J).
Embryos treated with 2 mM EGTA displayed an increased
permeability to 40 kDa FITC-dextran with 4863% of treated
blastocysts accumulating FITC-dextran in their cavities
(Figure 4G,J). Those blastocysts treated in 20 mM PP2 were
comparable to the EGTA treated group with 4362% of
permeable blastocysts, while treatment with 10
24 M ouabain
reduced tight junction permeability resulting in 1062% of treated
blastocysts accumulating FITC-dextran (Figure 4H,I,J). The
number of embryos examined for each respective treatment group
were: 54, 54, 41, 50 (Figure 4J). Analysis of this data set using the
Student-Neuman-Keul method demonstrated statistically signifi-
cant differences among all groups, except between EGTA and
20 mM PP2 treated blastocysts, P#0.05. The overall conclusion is
that PP2 treatment increased tight junction permeability equally
well as EGTA treatment. Thus SRC activity is a potent regulator
of tight junction permeability during mouse blastocyst formation.
Discussion
Our outcomes demonstrate that mRNAs encoding SFK family
members SRC and YES are detectable during preimplantation
development including blastocyst stage mouse embryos. Ouabain
treatment has concentration dependent effects on SFK activation;
higher concentrations known to block Na
+/K
+-ATPase transport
activity in mouse embryos reduce SRC activation, and lower
Figure 4. A–J. Effect of Ouabain and PP2 Treatment on Tight Junction Permeability using 4 kDa and 40 kda FITC-dextran in
Blastocysts. Representative images of embryos following 3 hour treatment of (A) KSOMaa, (B) 2 mM EGTA, (C)1 0
24 M ouabain, or (D)2 0mM PP2
using 4 kDa FITC-dextran. A significant difference was observed, P#0.05, in the number of embryos displaying 4 kDa FITC-dextran fluorescence
within the blastocyst cavity (E). Representative images of embryos following 3 hour treatment of (F) KSOMaa, (G) 2 mM EGTA, (H)1 0
24 M ouabain,
or (I)2 0mM PP2 using 40 kDa FITC dextran. A significant difference was observed, P#0.05, in the number of embryos displaying 40 kDa FITC-dextran
fluorescence within the blastocyst cavity, except between EGTA and PP2 treatment groups (J). The scale bars represent 100 mm.
doi:10.1371/journal.pone.0023704.g004
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ATPase ion transport enhance SRC activation. Blockade of SFK
activation reduces blastocyst cavitation in a concentration
dependent and in all cases a reversible manner, and more
importantly, increases trophectoderm tight junction permeability.
Conversely, ouabain treatment (10
24 M) that increases SFK
phosphorylation decreases trophectoderm tight junction perme-
ability. In total our results demonstrate that SFK activity facilitates
blastocyst formation and that SFKs are a potent mediator of
trophectoderm tight junction function in the blastocyst.
We first investigated the presence of SFK mRNAs during
preimplantaiton development to provide a foundation for our
studies. Our main focus was to determine if Src and Yes mRNAs
were present prior to and following blastocyst formation. There
are eight known SFK family members, Src and Yes, along with Fyn
are ubiquitously expressed [54]. Fgr is present in B cells and
myeloid cells, as are Lyn, Lck, Blk and Hck, which are also present
in T cells and brain tissue [54]. This more restricted expression
pattern would suggest that only Src, Yes and Fyn would be expected
to be present during early mouse development. We restricted our
analysis to include only Src and Yes as we were only able to obtain
reliable antisera for these two members of the SFK family. The
detection of mRNAs for Src and Yes during preimplantation
development and most importantly within blastocysts implies a
role for these SFK family members in regulating early develop-
ment and allowed for experiments aimed at determining which
kinases could be tethered to the Na
+/K
+-ATPase pump and
activated in the signaling pathway regulating tight junctions in the
preimplantation embryo. However, our results do not validate that
only Src, and Yes have a role to play in blastocyst formation as it is
quite possible proteins from other family members may be present
in the blastocyst and contribute to the outcomes reported in our
study. It will be important in the future to obtain effective antisera
for these additional family members to characterize their
localization patterns during preimplantation development.
Immunofluorescence revealed SRC and YES protein localiza-
tion patterns also during preimplantation development and most
importantly at the morula and blastocyst stages. SRC fluorescence
was more intense when compared to YES, however our results do
not precisely measure the abundance of these proteins. Immuno-
fluoresence is a sensitive method that is very effective at revealing
protein localization patterns. While several studies have developed
ways to quantify immunofluoresence signals it is challenging to
standardize conditions sufficiently to allow for a precise quantitia-
tion of target proteins levels to occur. Because of this limitation we
did not attempt to precisely measure variations in immunofluo-
rescence signals in this study. We have confined ourselves to
simply reporting consistent localization patterns and in providing
qualitative assessment of consistent and obvious changes in
fluorescence intensity following ouabain treatment. This is a
limitation of our study but providing quantitative fold differences
in fluorescence intensity may be misleading as its precise
relationship to protein abundance or phosphorylation cannot be
assured.
SRC has been linked to ouabain induced Na
+/K
+-ATPase
signalling in other cell systems such as cardiac myocytes, and
speculation exists that the other SFKs could be a part of their own
signalling pathway specific to different tissues [46,47]. The pattern
of protein localization was consistent for SRC, which was
detectable at cell margins within the 2-cell embryo, diminishing
during compaction, reappearing afterwards and present in all cells
of the blastocyst. The significance of appearing at basolateral cell
domains cannot be overlooked, as this pattern mimics the well-
known distribution of the Na
+/K
+-ATPase in the trophectoderm
[19,22,25,55,56]. Therefore SRC, and possibly YES, may be co-
localized with the Na
+/K
+-ATPase pump in a signalling complex
regulating tight junctions. Although it is possible that all SFKs
interact with the Na
+/K
+-ATPase because of their similar
structure, it would likely be in a tissue specific manner due to
the difference in signals and protein distribution among cell types
[46,47]. Another intriguing possibility is that the activation of a
specific SFK may elicit specific Na
+/K
+-ATPase responses.
Many studies report that high concentrations of ouabain will
block the ion transport function of the rodent Na
+/K
+-ATPase a1-
subunit, while lower concentrations will activate signalling
pathways transduced through SRC [20,23,32,34,38,40,47–
49,51,53]. Low CTS concentrations are demonstrated to stimulate
Na
+/K
+-ATPase activity in cardiac myocytes, by way of activating
SRC/EGFR, PI3K and ROS production [44,48,49]. Na
+/K
+-
ATPase a1 knockout studies have even demonstrated increased
basal SRC activity, and the loss of ouabain induction of SRC
signalling (reviewed in [40–42]. In other studies, using SYF (Src,
Yes, Fyn triple deletion) cells or pre-treating cells with PP2, caused
ouabain to lose its ability to activate ERK [44,46–49].
Studies report maximal ouabain effects between 2 and
5 minutes, followed by depletion of its effects in cells [57,58].
Our study suggests ouabain regulation of SRC activity occurs
through their mutual association with the Na
+/K
+-ATPase pump.
Although these outcomes were consistent and novel, the results did
not convincingly exhibit a maximal effect following 2 minutes.
Following 10 minutes of ouabain treatment, obvious differences
between the level of fluorescence of tyr418 was observed between
treatment groups. Blastocysts treated with 10
23 M ouabain
exhibited a reduction in tyr418 phosphorylation fluorescence
while those treated in 10
24 M ouabain demonstrated an increase
in tyr418 phosphorylation fluorescence. Of greater significance,
the percentage of embryos exhibiting higher tyr418 phosphoryla-
tion fluorescence doubled in the 10 minute group when compared
to blastocysts treated for 2 min. The 10 minute treatment also
resulted in higher intensity fluorescence when compared to the
2 min group, suggesting a time dependent aspect of ouabain
stimulated SRC activity. This outcome has revealed a novel mode
of SRC regulation in the blastocyst. This, together with the
localization of SRC protein to the basolateral domain of
embryonic cells, and the existing literature showing ouabain
eliciting its effects through the Na
+/K
+-ATPase, implicates the
pump in this signalling pathway in the mouse blastocyst. An
important limitation of our study is that we were not able to
precisely measure these changes in tyr418 phosphorylation by
employing methods such as Western blotting. The primary reason
for this was attempts to perform this analysis using samples derived
from several 100 blastocysts per lane failed in detecting either total
SRC, Yes or phosphorylated SRC. This is not completely
surprising as the application of Western blotting methods to
quantify protein changes during preimplantation stage embryos
often fail even with the application to samples derived from 100’s
of early embryos due to low overall protein abundance in such
samples. While we do not report specific fold changes in
fluorescence the observations we do report were consistent and
while qualitative in nature due reflect obvious changes in
fluorescence intensity representative of tyr418 phosphorylation.
We have validated the specificity of the antisera used in this study
by conducting tissue and cell sample Western blots (Figure S1). In
addition we employed commercially sourced antisera that have
been employed and validated in several publications employing
them for the same purpose we have in this study [59–62].
PP2 is a widely used specific and effective SFK inhibitor [63].
PP2 binds between the two lobes of the kinase domain and
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binds near the ATP binding pocket, and since the sequences
adjacent to the ATP binding pockets are very different between
the SFKs, these areas may be the true binding sites [64]. PP2
concentrations used were 20, 30 and 50 mM and were compared
to culture control KSOMaa and vehicle control KSOMaa plus
DMSO. The first set of experiments demonstrated all concentra-
tions of PP2 significantly blocked morulae from developing into
blastocysts when compared to either control group. Importantly,
the majority of embryos were able to recover from the treatment
and reach the blastocyst stage once thoroughly washed. Immuno-
fluorescence demonstrated that PP2 blocked phosphorylation of
tyr418 of SRC. These results together demonstrate the significance
of SFK activity for blastocyst development.
Further confirmation of these outcomes was provided by
culturing morulae in 1, 5 or 10 mM of SU6656, which produced
identical results to the PP2 experiments. SU6656 selectively inhibits
SRC, YES and FYN, although SRC is 6.5 fold more sensitive than
the other two SFKs [65]. It acts by competitively competing for
ATP but does not affect MAPK activation [65]. SU6656 is highly
specific and has greater potency of action than PP2 and does not
block any other molecule to the degree that it inhibits SRC [65].
The two higher doses of SU6656 used significantly blocked morulae
from becoming blastocysts. The concentrations of SU6656 used in
this study are well defined [66], those of PP2 are in the micromolar
range in order to elicit its effect on intact cells, such as embryos, as
reported in literature [67]. Our studies demonstrated no difference
in effects on embryonic cavitation with 1 mM, 5 mm, or 10 mM PP2.
An additional limitation of our study is that while we determined
that SRC inhibition treatmentswerereversibleand treatedembryos
were able to proceed to the blastocyst stage once removed from
treatment, we did not measure cell numbers in the recovered
blastocysts.Theprimaryreasonfor this was that wewerefocused on
ensuring that our treatment levels were not embryo toxic and that
an ability to reach the blastocyst stage following treatment certainly
indicates that the concentrations used were not embryo toxic.
However our results do not in any way suggest that embryo viability
was not compromised as we did not test for this, which would
require embryo transfer experiments and assessment of pregnancy
outcomes which was beyond the scope of the present study.
Tight junctions between adjacent cells form a continuous barrier
to epithelial paracellular transport [12,28,29,68,69]. They provide
the impermeable seal allowing fluid accumulation within the
blastocyst cavity and contribute to the polarized distribution of the
Na
+/K
+-ATPase pump in the basolateral membrane of the
trophectoderm [12,28,29,68,69]. Tight junctions play an integral
role in blastocyst development and as such, our primary objective
was to investigate whether SRC activity regulates trophectoderm
tight junction function during blastocyst development. Although
Wiley [53] reported that high or low doses of ouabain had no effect
onthe appearanceof tight junctions, theeffects of ouabaintreatment
on tight junction function were not investigated in that study.
The FITC-dextran permeability assay is a sensitive method
ideally suited for assessing tight junction functionality [23,31]. By
visualizing the amount of the molecule permeating the tight
junctions and accumulating within the blastocyst cavity, conclu-
sions can be drawn regarding their permeability and thus function.
In these experiments, we observed that inhibition of SFK by PP2
increased tight junction permeability to a percentage comparable
to the positive control EGTA. Of the approximately 100 embryos
examined in each treatment group incubated in 4 kDa FITC-
dextran, 48% were permeable when treated in EGTA, while 34%
were when treated with PP2. These percentages were significantly
different from each other signifying that PP2 was not as effective as
EGTA in opening tight junctions. However, the PP2 treated
embryos were more permeable to 4 kDa FITC-dextran when
compared to KSOMaa control treated embryos, which exhibited
22% permeability.
This effect was also observed using 40 kDa FITC-detxtran,
which showed no statistical significance between the EGTA and
PP2 treated groups. This outcome establishes that SFK inhibition is
just as effective at disrupting tight junction function as EGTA
treatment. Remarkably, 10
24 M ouabain affected tight junction
function by decreasing their permeability to 4 or 40 kDa FITC-
dextran. Both experimental outcomes demonstrate that SRC
activation is associated with decreased trophectoderm tight junction
permeability. Recently, it has been suggested that SRC may be able
to directly or indirectly interact with ZO-1 and this provides a route
for understanding how SRC activation may regulate tight junction
function [70]. Our earlier studies (Violette et al., [23] established
that high ouabain treatment (10
23 M) is associated with disrupted
tightjunctionassociated protein(ZO-1and occluden)distributionin
treated blastocysts. In addition, it was reported by Violette [23] that
high ouabain treatment increased tight junction permeability.
These outcomes cannow be understood dueto ourpresentstudy, as
our findings indicate that high ouabain treatment would reduce
SRC activation and this in turn would result in increased
trophectoderm tight junction permeability. Recently, we also
discovered that down-regulationof the Na
+/K
+-ATPase b1-subunit
results in a loss of blastocyst formation, also associated with a
disrupted trophectoderm tight junction associated protein distribu-
tion [22]. It is thus intriguing to consider the possibility that the
Na
+/K
+-ATPase b1-subunit may also be subject to SFK regulation.
These will represent the subject of our future experiments. In
addition, the ouabain-Na
+/K
+-ATPase-SRC complex is often
associated with activation of ERK1/2, and now that SRC is
implicated in interacting with ZO-1, regulation of trophectoderm
tight junctions through this signalling cascade is very likely.
In conclusion, this study has investigated the unconventional
function of the Na
+/K
+-ATPase pump as a signal transducer,
rather than an ion transporter responsible for maintaining osmotic
gradients. A number of novel findings pertaining to blastocyst
development have been uncovered. Firstly, Src and Yes mRNAs
and protein are detectable at the blastocyst stage. Secondly,
10
23 M ouabain reduces SFK activity, whereas 10
24 M ouabain
increases tyr418 phosphorylation. Localizing SRC in the baso-
lateral domain of blastocyst cells, and identifying that SFK activity
is regulated by CTS, strongly suggests the involvement of the Na
+/
K
+-ATPase in transducing this signal. Thirdly, SFK activity is
required for blastocyst development. Lastly, SFKs regulates
trophectoderm tight junction function in the blastocyst. Consid-
ering that little is known of how tight junctions could be regulated
in the blastocyst, or of the signaling cascade initiated by CTS
binding to the Na
+/K
+-ATPase in embryos, this study has
increased our understanding of the mechanisms controlling
blastocyst formation. It would seem to be reasonable to propose
that the Na
+/K
+-ATPase is present in caveolae of the trophec-
toderm, creating a signalosome capable of transducing SFK signals
following ouabain activation of the Na/K-ATPase. This research
therefore addresses the basic mechanisms controlling early
mammalian development and has uncovered new principles for
understanding how blastocyst formation is regulated.
Materials and Methods
Mouse Preimplantation Embryo Collection
Female CD1 (3–5 weeks of age; The Jackson Laboratory, Bar
Harbor, Maine, USA) or MF1 mice (3–5 weeks of age; Harlan
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intraperitoneal (IP) injection of 5 IU pregnant mare’s serum
gonadotropin (PMSG, Intervet Canada Ltd, Whitby, ON, Canada)
followed 48 hours later by 5 IU human chorionic gonadotropin
(hCG; Intervet Canada Lts., Whitby, ON, Canada). Superovulated
female mice weremated with CD1 males (8–52 weeksofage,Charles
River, Quebec, Canada). Successful mating was indicated by the
presence of a vaginal plug the following morning (day 1). Time post-
hCG was used to measure the developmental age of the embryos.
Preimplantation mouse embryos were collected at 18 hours (1-cell),
48 hours (2-cell), 55 hours (4-cell), 66 hours (8-cell), 77 hours
(morula) and 90 hours (blastocyst) post hCG. All embryo stages were
flushed from the reproductive tract using M2 medium (Sigma,
St.Louis, MO, USA). Embryos were washed several times in M2
medium with HEPES or KSOMaa and collected in pools to be 1)
frozen at 280uC until their use in RNA extraction; 2) fixed for
indirect immunofluorescence; or 3) cultured in EmbryoMaxH
KSOMaa (potassium simplex optimized medium with amino acids)
Liquid Mouse Embryo Media (Chemicon International – Specialty
Media, Temecula, CA, USA) under mineral oil and maintained in
culture under 5% CO2 in air atmosphere at 37uCf o rt h et i m e
outlined by the experimental design. All animal care and embryo
collection methods were conducted using approved protocols from
the Canadian Council of Animal Care and the University of Western
Ontario Animal Care and Veterinary Services. The approved
UniversityofWesternOntarioanimalcareprotocolnumberforthese
studies is 2010-021Watson.
RNA Extraction
Total RNA was extracted from pools of 20 or 40 preimplan-
tation stage mouse embryos, stored at 280uC in M2 medium with
HEPES immediately after collection, using the PicoPureH RNA
Isolation Kit (Arcturus, Molecular Devices, Sunnyvale, CA, USA).
Samples were treated with DNAse I (Qiagen Inc., Mississauga,
ON, Canada) to remove any possible DNA contamination.
Reverse Transcription and Polymerase Chain Reaction
(RT-PCR)
Total RNA was reverse transcribed (RT) using the suggested
protocol of Sensiscript RT (Qiagen Inc., Mississauga, ON,
Canada). Each sample was diluted to a concentration of one
embryo equivalent per microliter. PCR reactions were carried out
in a volume of 50 mL consisting of 5 mL1 0 6 PCR buffer, 2 mL
50 mM magnesium chloride, 1 mL 10 mM dNTP (all above from
Invitrogen Life Technologies, Burlington, ON, Canada), 1 mMo f
each appropriate PCR primer, 38.8 mL HyPure
TM water
(Hyclone, Thermo Fisher Scientific Inc., Ottawa, ON, Canada),
0.2 mL PlatimumH Taq DNA Polymerase (Invitrogen Life
Technologies, Burlington, ON, Canada) and 1 mL cDNA for the
embryonic stage being tested. Amplification reactions were
performed using a Techne Touchgene Gradient DNA thermal
cycler (Techne Inc., Burlington, NJ, USA). PCR reactions were
repeated a minimum of three times using cDNA prepared from
embryos at each indicated stage, isolated from a minimum of three
developmental series (2-cell, 4-cell, 8-cell, morula and blastocyst
stages). Positive (lung tissue cDNA) and negative control (no cDNA
template) samples were included for each primer set in each
experiment. Lung RNA was extracted by the Trizol ReagentH
protocol suggested by the manufacturer (Molecular Research
Center Inc., Cincinnati, OH, USA). The identity of each PCR
product was confirmed by sequence analysis which resulted in a
100% sequence identity for both the Src and Yes PCR products
derived from embryo and control samples (DNA Sequencing
Facility, Robarts Research Institute, London, On, Canada).
Primer Design
Primer pairs for PCR were designed and synthesized (Invitrogen
Life Technologies, Burlington, ON, Canada) for Src, and Yes,
based on available mouse nucleotide sequences in GenBank.
Antisera
Rabbit polyclonal antiserum raised against the phosphorylated
tyrosine residue 418 of human SRC (ab481650, abcam, Cam-
bridge, MA, USA) was utilized at a dilution of 1:100 to localize
SRC phosphorylation in mouse embryos. Rabbit polyclonal
antisera against total human SRC (#2108, Cell Signaling
Technology, Danvers, MA, USA) and human YES (#2734, Cell
Signaling Technology, Danvers, MA, USA) were used at dilutions
of 1:200 to localize the proteins in mouse embryos. Western
blotting utilizing standard SDS-polyacrylamide Gel Electrophore-
sis (PAGE) and chemi-luminescence detection methods was
applied to verify the specificity of the SRC and YES antisera
employed in the study (Figure S1).
Whole-mount Indirect Immunofluorescence and
Confocal Microscopy
Mouse preimplantation stage embryos were collected from the
reproductive tracts of superovulated female mice as described
above. Embryo pools were fixed in 2% paraformaldehyde in PBS
for 20 minutes at room temperature. Fixed embryos were
incubated in embryo blocking buffer (0.01% Triton X-100 and
5% Normal Donkey Serum in 16PBS) for 1 hour followed by one
wash in 16PBS for 20 minutes at 37uC. Embryos were incubated
with primary antisera diluted in antibody dilution buffer (ADB)
(0.005% Triton X-100 and 1% Normal Donkey Serum in 16
PBS) for 1 hour at 37uC or overnight at 4uC. Embryos were then
washed 36in ADB for 30 minutes at 37uC, then incubated with
FITC-conjugated secondary antibody (Jackson ImmunoResearch
Laboratories Inc., West Grove, PA, USA) at a 1:200 dilution in
ADB for 1 hour at 37uC or overnight at 4uC. To stain nuclear
DNA, the first 30 minute wash in ADB included 49,6-diamindino-
2-phenylindole dihydrochloride (DAPI) (Sigma-Aldrich Cananda
Ltd., Oakville, ON, Canada), diluted to 1:2000 from 1 mg/mL
stock solution. Two additional washes in 400 mL ADB of
30 minutes each at 37uC were applied. Fully processed embryos
were mounted onto glass slides in a drop of Vectashield (Vector
Laboratories; Burlington, Ontario, Canada) under Vaseline-
elevated glass coverslips and sealed with nail polish. Immunoflu-
orescence imaging employed an Olympus Fluoview 1000 laser
scanning confocal microscope. For all immunofluorescence
protocols, embryos serving as negative controls were incubated
in ADB rather than primary antibody.
Effects of Ouabain Treatment on Blastocyst SRC Activity
Culture drops of KSOMaa were equilibrated at 37uC and 5%
CO2 in air atmosphere for 1 hour. Blastocysts were flushed from
mouse uteri, washed thoroughly through M2 medium with
HEPES, then KSOMaa and were incubated in 20 mL KSOMaa
drops for 1 hour, after which they were placed in KSOMaa/
ouabain (10
23 M, 10
24 M) for 2 or 10 minutes. Immediately
following ouabain treatment, blastocysts were fixed in 2%
paraformaldehyde for 20 minutes at room temperature and were
then immunostained for phosphorylation of tyr418 of SRC.
SFK Inhibition of Mouse Embryos (PP2, SU6656)
Culture drops of KSOMaa, DMSO (vehicle control for PP2),
and PP2 (20 mM, 30 mM, 50 mM) were incubated for 1 hour at
37uC and 5% CO2 in air atmosphere. Morulae were flushed from
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KSOMaa and placed into 20 mL culture drops of KSOMaa, or
KSOMaa plus DMSO, or KSOMaa plus PP2. Morulae were
cultured for 18 hours at which time progression to the blastocyst
stage was assessed. SU6656 at concentrations of 1 mM, 5 mM,
10 mM were also used in the same experimental design described
above.
Measurement of Tight Junction Function by FITC-
Dextran Uptake Assay
To investigate the effects of SRC inhibition on tight junction
permeability, blastocysts were flushed from uteri, were washed
through KSOMaa and placed into 15 mL culture drops of
KSOMaa, KSOMaa/2 mM EGTA (ethylene glycol Bis- (b-
aminoethyl ether) N,N,N,N -tetraacetic acid), KSOMaa/10
24 M
ouabain or KSOMaa/20 mM PP2 for 3 hours. After the 3 hour
time point, blastocysts were transferred to 4 or 40 kDa FITC-
dextran in KSOMaa for 30 minutes. Following this incubation,
blastocysts were immediately washed in three 50 mL wash drops of
KSOMaa and placed in a fourth clean KSOMaa drop for
immediate visualization using a Zeiss fluorescent compound
microscope equipped with epi-fluorescent optics.
Statistical Analysis
Statistical analysis of data was performed using SigmaStatH,
version 3.5, software. The results from culture in ouabain, PP2 and
SU6656 are all presented as the mean 6 standard error from three
independent experimental replicates. For testing significant
differences between culture groups, data were subjected to one-
way analysis of variance (ANOVA). Data analysis for ouabain and
PP2 trials passed normality tests and were followed by the Holm-
Sidak post hoc test. Data for the SU6656 and tight junction
permeability experiments were evaluated by applying an ANOVA
on ranks. As a post-hoc test, the Student-Neuman-Keul method
was employed. For all data analysis, P#0.05 was considered
statistically significant.
Supporting Information
Figure S1 A,B. Supplementary Data – Src and Yes
antiserum western blotting in control tissues. SRC and
YES antibodies were tested on liver, pancreas, mammary and
cancerous acinar cell line control protein extracts (A,B). The SRC
antiserum resulted in the detection of a single band of expected
molecular weight (60 kDa) in liver and AR42J (A). SRC protein
was not detected in mammary protein samples but was detected in
both total pancreas tissue samples (A). The doublet detected in
pancreatic tissue is suggestive of SRC phophorylation in this tissue
(A). Western blot conducted using the YES antiserum also
validated the specificity of the antiserum in the two pancreas
protein tissue samples by producing bands of expected size in each
sample (B). Yes protein was undetectable in liver, mammary gland
tissue or AR42J cells (B).
(TIF)
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